首页 | 本学科首页   官方微博 | 高级检索  
     


Modelling and simulation in the pharmaceutical industry--some reflections
Authors:Burman Carl-Fredrik  Wiklund Stig Johan
Affiliation:Statistics & Programming, AstraZeneca R&D, M?lndal, Sweden. carl-fredrik.burman@astrazeneca.com
Abstract:Modelling and simulation (M&S) is increasingly being applied in (clinical) drug development. It provides an opportune area for the community of pharmaceutical statisticians to pursue. In this article, we highlight useful principles behind the application of M&S. We claim that M&S should be focussed on decisions, tailored to its purpose and based in applied sciences, not relying entirely on data-driven statistical analysis. Further, M&S should be a continuous process making use of diverse information sources and applying Bayesian and frequentist methodology, as appropriate. In addition to forming a basis for analysing decision options, M&S provides a framework that can facilitate communication between stakeholders. Besides the discussion on modelling philosophy, we also describe how standard simulation practice can be ineffective and how simulation efficiency can often be greatly improved.
Keywords:
本文献已被 PubMed 等数据库收录!
正在获取相似文献,请稍候...
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号